New heart valve device tested in tiny early study
NCT ID NCT07116551
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early study is testing a new balloon-expandable heart valve system from Abbott for people with severe, symptomatic aortic stenosis. The valve is delivered through a catheter, avoiding open-heart surgery. Only 11 participants are enrolled to check if the device is safe and works as intended.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Abbott BE TAVI System (a balloon-expandable heart valve replacement device)
What this could lead to
If successful, this could lead to a new, less invasive option for replacing a narrowed heart valve, potentially improving survival and quality of life for people with severe aortic stenosis.
What could go wrong
This is a very early, small study with only 11 people, so results may not apply to everyone. The device could fail or cause complications like bleeding, stroke, or need for a permanent pacemaker.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYMPTOMATIC SEVERE AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abbott Northwestern Hospital
Minneapolis, Minnesota, 55407, United States
-
Clinique Pasteur Toulouse
Toulouse, Midpyre, 31076, France
-
Columbia University Medical Center/New York-Presbyterian
New York, New York, 10032, United States
-
Montefiore Medical Center - Moses Division
The Bronx, New York, 10461, United States
-
Via Christi Regional Medical Center
Wichita, Kansas, 67214, United States